New book by Larry Connors Click here Improve your trading - See how
The indices started the week on a negative note, but it sure was different in the morning. The day started out with a sharp move up, testing the highs on the Nasdaq 100, forming a triple top of sorts there, but couldn’t punch through. The S&P 500 at the same time reached as high as 1092 and tagged is 4-day declining tops line, but failed there as well. They then sold off very sharply in late morning trade, with the NDX dropping from 1778 to 1740, a 38-point drop in less than an hour, and the SPX dropping 25 ,from 1091 to 1066. Over the course of the rest of the session, they basically backed and filled, consolidated, but failed to break out either way, but closed negatively. Net on the day the Dow was down 104.22 at 9867.96, and the S&P 500 down 12.65 to 1066.95, just a point and half off its low. The Nasdaq 100 closed down 6.88 to 1746.75. Advance-declines were better than 3 to 1 negative on New York and about 2 1/2 to 1 negative on Nasdaq. Up/down volume was the story, however, today, with about a 7 to 1 negative ratio on New York on total volume of just under 1.4 billion. Nasdaq traded 2.3 billion and had about a 2 1/2 to 1 negative volume ratio. TheTechTrader.com board closed mostly narrowly mixed on the downside. However, there were some gainers of note. The Direxion Financial Bear 3x Shares (FAZ) gained 1.31 to 20.68. Portfolio position BioCryst Pharmaceuticals (BCRX) jumped 1.28 to 10.94, reaching as high as 11.31 earlier on 12 1/3 million traded. Other flu vaccine stocks were firm, with Sinovac (SVA) up 57 cents to 8.06, and NovaVax (NVAX) up 34 cents to 4.38. Opexa Therapeutics (OPXA) jumped 22 cents to 2.54, and Nanometrics (NANO) 19 cents to 7.56. Ultrashorts were firm today, with the Direxion Large Cap Bear 3X Shares (BGZ) up 68 cents to 20.45 and the Direxion Small Cap 3x Bear (TZA) up 36 cents to 12.32. On the downside, the Direxion Financial Bull 3x Shares (FAS) lost 5.69 to 77.83, and American International Group (AIG) gave back 2.65 to 36.25. Financials were weak with Goldman Sachs (GS) off a point, JP Morgan (JPM) down 1.21, and Wells Fargo (WFC) 87 cents. Stepping back and reviewing the hourly chart patterns, they were up early, down sharply before mid-day, and then consolidated for the rest of the session, ending to the downside to start the week in a continuation of Friday’s weakness as the SPX went to new multi-session lows. We’ll see if this continues during the course of the rest of the week and what kind of follow-through we get tomorrow. Good trading! Harry For more of Harry Boxer, sign up for a Free 15-Day Trial to his Trading Diary. (https://www.thetechtrader.com/reg/bb) thetechtrader.com For full details on Biocryst Pharmaceuticals (BCRX) click here. Biocryst Pharmaceuticals (BCRX) has Short Term PowerRatings of 5. Details on Biocryst Pharmaceuticals (BCRX) Short Term PowerRatings is available at This Link.
Email Print Archives Feedback Email Article Link
Close X
Related News [BCRX]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
Premium Subscription Services
RELATED SITES
Please call 1-213-955-5858 ext. 1
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. The Connors Group, Inc. © Copyright 2009 The Connors Group, Inc. All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2009 The Connors Group, Inc.
|
